Physician profile
Alan R Taylor
NPI 1104898352
$4,788.67
in general payments reported to CMS, 2019-2025
26 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what 99% of Home Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $617).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.52 · 2022: $1,670 · 2023: $899 · 2024: $981 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,990 · Gift: $59.40 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,989.96 |
| Gift | $59.40 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $1,304.75 | 2022-2025 | Afrezza |
| Lilly USA, LLC | $574.45 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Bioventus LLC | $492.32 | 2022 | |
| Medtronic, INC. | $421.18 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $402.62 | 2022-2025 | Xtampza |
| Novo Nordisk INC | $334.70 | 2024-2025 | Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $177.10 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Boston Scientific Corporation | $142.26 | 2024 | |
| Sanofi-Aventis U.S. LLC | $104.15 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $103.69 | 2022-2025 | Farxiga |
| Sequel Med Tech, LLC | $102.58 | 2025 | Twiist |
| Tolmar, INC. | $97.21 | 2023-2025 | Jatenzo |
| Amgen INC. | $58.50 | 2025 | Tepezza |
| Merck Sharp & Dohme LLC | $56.93 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $54.59 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuity Medical INC | $54.51 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascensia Diabetes Care US INC. | $53.73 | 2024 | |
| Acella Pharmaceuticals, LLC | $45.58 | 2023 | NP Thyroid 60 |
| Insulet Corporation | $40.23 | 2023-2024 | Omnipod |
| Averitas Pharma INC. | $35.05 | 2025 | Qutenza |
| Abbvie INC. | $25.65 | 2024 | |
| Radius Health, INC. | $25.50 | 2023 | Tymlos |
| Abbott Laboratories | $22.19 | 2023 | Freestyle Libre 3 |
| Grt US Holding, INC. | $22.12 | 2022 | |
| Beta Bionics, INC. | $20.69 | 2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $16.39 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.